Revenue volatility remains high, evidenced by a 31.5% year-over-year decline and an operating margin that reached a deeply negative level in recent periods as R&D expenditures consistently outpace income.
| Sales/Revenue | 241.88K | 231.21K | 337.52K | 109.63K | 0 | 37.93K | 234.47K | 110K | 110K |
| Revenue Growth % | -6.54% | -31.5% | 207.87% | - | -100% | -83.82% | 113.15% | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - |
| Gross Profit | 241.88K | 231.21K | 337.52K | 109.63K | 0 | 37.93K | 234.47K | 110K | 110K |
| Gross Margin % | 100% | 100% | 100% | 100% | - | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | - | -31.5% | 207.87% | - | -100% | -83.82% | 113.15% | - | - |
| Operating Expenses | 17.71M | 12.07M | 7.73M | 5.94M | 4.76M | 3.21M | 429.36K | 356.45K | 356.45K |
| OpEx % of Revenue | - | 5222.16% | 2290.26% | 5418.81% | - | 8455.2% | 183.12% | 324.05% | 324.05% |
| Selling, General & Admin | 9.74M | 6.08M | 4.04M | 3.26M | 3.67M | 2.87M | 369.8K | 236.01K | 236.01K |
| SG&A % of Revenue | - | 2629.25% | 1197.15% | 2974.46% | - | 7564.54% | 157.72% | 214.56% | 214.56% |
| Research & Development | 7.36M | 5.46M | 3.26M | 2.53M | 1.04M | 310.63K | 13.27K | 0 | 0 |
| R&D % of Revenue | - | 2360.96% | 965.37% | 2306.33% | - | 818.95% | 5.66% | - | - |
| Other Operating Expenses | 612.51K | 536.3K | 431.15K | 151.31K | 60.63K | 27.2K | 46.3K | 120.44K | 120.44K |
| Operating Income | -17.47M | -11.84M | -7.39M | -5.83M | -4.76M | -3.17M | -194.89K | -246.45K | -246.45K |
| Operating Margin % | -7223.12% | -5122.16% | -2190.26% | -5318.81% | - | -8355.2% | -83.12% | -224.05% | -224.05% |
| Operating Income Growth % | - | -60.2% | -26.78% | -22.38% | -50.35% | -1526.08% | 20.92% | - | - |
| EBITDA | -16.86M | -11.31M | -6.96M | -5.68M | -4.7M | -3.11M | -148.6K | -246.45K | -246.45K |
| EBITDA Margin % | -6969.89% | -4890.21% | -2062.51% | -5180.79% | - | -8204.37% | -63.38% | -224.05% | -224.05% |
| EBITDA Growth % | -71.77% | -62.42% | -22.57% | -20.74% | -51.17% | -1994.2% | 39.71% | - | - |
| D&A (Non-Cash Add-back) | 612.51K | 536.3K | 431.15K | 151.31K | 60.63K | 57.21K | 46.3K | 0 | 0 |
| EBIT | -18.12M | -12.13M | -7.42M | -5.85M | -5.04M | -3.15M | -203.79K | -246.45K | -246.45K |
| Net Interest Income | 82.42K | -27.04K | -31.67K | -25.95K | -46.35K | -68.43K | -49.21K | 1.53K | 1.53K |
| Interest Income | 98.36K | 0 | 0 | 0 | 0 | 0 | 0 | 1.53K | 1.53K |
| Interest Expense | 15.94K | 27.04K | 31.67K | 25.95K | 46.35K | 68.43K | 49.21K | 0 | 0 |
| Other Income/Expense | -661.7K | -302.74K | -44.4K | -32.35K | -315.77K | -39.61K | -53.09K | 1.53K | 1.53K |
| Pretax Income | -18.13M | -12.15M | -7.44M | -5.86M | -5.08M | -3.21M | -247.98K | -244.92K | -244.92K |
| Pretax Margin % | -7496.69% | -5253.1% | -2203.41% | -5348.33% | - | -8459.63% | -105.76% | -222.65% | -222.65% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -18.13M | -12.15M | -7.44M | -5.86M | -5.08M | -3.21M | -247.98K | -244.92K | -244.92K |
| Net Margin % | -7496.69% | -5253.1% | -2203.41% | -5348.33% | - | -8459.63% | -105.76% | -222.65% | -222.65% |
| Net Income Growth % | -77.93% | -63.32% | -26.84% | -15.41% | -58.34% | -1193.95% | -1.25% | - | - |
| Net Income (Continuing) | -18.13M | -12.15M | -7.44M | -5.86M | -5.08M | -3.21M | -247.98K | -244.92K | -244.92K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.55 | -0.45 | -0.36 | -0.33 | -0.41 | -1.05 | -0.18 | -0.11 | -0.10 |
| EPS Growth % | -54.59% | -25% | -9.09% | 19.51% | 60.95% | -483.33% | -63.64% | - | - |
| EPS (Basic) | - | -0.45 | -0.36 | -0.33 | -0.41 | -1.05 | -0.18 | -0.11 | -0.10 |
| Diluted Shares Outstanding | 32.95M | 27.23M | 20.43M | 17.55M | 12.41M | 5.5M | 1.37M | 2.16M | 2.16M |
| Basic Shares Outstanding | 32.95M | 27.23M | 20.43M | 17.55M | 12.41M | 5.5M | 1.37M | 2.16M | 2.16M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
Pre-commercial cash runway exhaustion
As reported in recent financial filings, Aduro Clean Technologies experienced a 31.5% year-over-year revenue decline, highlighting the non-recurring nature of its current project-based income streams which remain highly sensitive to the timing of feasibility studies and grant-funded research milestones rather than consistent commercial product sales.
The erratic revenue profile suggests that the company has yet to establish a repeatable commercial model, leaving top-line performance at the mercy of sporadic partnership agreements. Investors should monitor whether future revenue can transition from these transactional pilot fees to a more predictable licensing-based income stream.
Based on the provided income statement data, the company's cost structure is dominated by heavy research and development expenditures, which have consistently outpaced revenue and contributed to an operating margin that reached a deeply negative -5122.16% in the most recent period of reported activity.
This cost profile is characteristic of an early-stage technology firm prioritizing intellectual property development over immediate profitability. The lack of traditional COGS suggests that the company is not yet manufacturing at scale, meaning the current expense discipline is entirely focused on sustaining the laboratory-based burn rate.
According to historical financial statements, the company's net loss figures are significantly impacted by recurring stock-based compensation, which reached $1.2 million in the most recent quarter, suggesting that reported earnings quality is heavily diluted by non-cash equity incentives used to preserve limited liquid cash reserves.
The reliance on equity-based compensation may indicate management's attempt to align incentives while managing a precarious cash position. Analysts should adjust for these non-cash charges to better understand the underlying operational cash burn that threatens the company's long-term viability.
While the company touts its proprietary Hydrochemolytic Technology, the lack of meaningful revenue and the persistent negative operating margins suggest that the market may be overestimating the speed at which this technology can transition from laboratory-scale validation to a commercially viable, revenue-generating industrial process.
Short-sellers would likely focus on the potential for significant future dilution as the company attempts to bridge the gap between its current pilot-stage operations and full-scale commercialization. The absence of a clear path to positive cash flow warrants extreme caution regarding the company's long-term capital requirements.
Quick answers to the most common questions about buying ADUR stock.
For fiscal year 2025, Aduro Clean Technologies Inc. (ADUR) reported total revenue of $0.2M. This represents a 110.2% increase compared to $0.1M in 2018.
Aduro Clean Technologies Inc. (ADUR) reported a net loss of $12.1M for the fiscal year ending 2025.
Aduro Clean Technologies Inc. (ADUR) reported an operating income of $-11.8M, resulting in an operating profit margin of -5122.2%. This margin reflects the operational efficiency of the business before interest and taxes.
Aduro Clean Technologies Inc. (ADUR) generated $0.2M in gross profit for the year, representing a gross profit margin of 100.0%. This demonstrates the company's core pricing power and production efficiency.